Prime Medicine (NYSE:PRME) Upgraded at StockNews.com
StockNews.com upgraded shares of Prime Medicine (NYSE:PRME – Free Report) to a sell rating in a report released on Tuesday. A number of other equities research analysts have also recently issued reports on PRME. HC Wainwright reaffirmed a “buy” rating and issued a $10.00 price objective on shares of Prime Medicine in a research note […]
StockNews.com upgraded shares of Prime Medicine (NYSE:PRME – Free Report) to a sell rating in a report released on Tuesday. A number of other equities research analysts have also recently issued reports on PRME. HC Wainwright reaffirmed a “buy” rating and issued a $10.00 price objective on shares of Prime Medicine in a research note […]
